Jelena Drulović on regional scientific collaboration as a driver of better MS care

In this short video interview, Jelena Drulović discusses the value of scientific collaboration across the Balkan region and how joint research efforts can translate directly into improved care for people with multiple sclerosis.

Watch the interview

Why is regional scientific collaboration particularly important in multiple sclerosis research and care?

In the interview, Jelena Drulović explains how cooperation across countries enables stronger science and more effective translation of evidence into clinical decision-making.

Key points discussed include:

• The importance of structured scientific collaboration across the Balkan region
• The advantage of pooling data to study rare or underrepresented MS-related conditions
• A regional study on epilepsy and quality of life in MS patients as a practical example
• The ability to generate statistically and clinically significant results through collaboration
• How shared research efforts lead to successful publication and knowledge dissemination
• The direct translation of scientific findings into improved patient care
• Evidence that optimal treatment of seizures in MS patients is crucial
• Collaboration as a foundation for developing better treatment strategies in daily practice

How do you see the role of collaboration between Balkan countries in advancing MS care and education?

* Please note that all the captions were generated automatically. If they do not appear, click on CC in the navigation.

Key messages from Prof. Jelena Drulović

Scientific collaboration is not only beneficial, it is essential for advancing multiple sclerosis care. In the interview, Jelena Drulović highlights that working together across countries allows clinicians to study rare conditions more effectively, produce meaningful results, and apply those insights directly to patient management.

By translating shared scientific findings into everyday clinical strategies, regional cooperation helps ensure that research outcomes lead to tangible improvements in patient care. Overall, the interview underscores collaboration as a powerful tool for turning evidence into better outcomes for people living with multiple sclerosis.

Curious to learn more about the expert behind this interview?

Visit Jelena Drulović’s full biography for more insights into her expertise.

We value your opinion.

recommend think this

How likely are you to recommend this material to a friend or colleague?

Selected Value: 1

Give a score from 1 (= not at all likely) to 10 (extremely likely)

Tell us what you think or ask a question to the expert.

Give your opinion on the quality of the material and send us your comments, questions or feedback. Where relevant, we'll liaise with the Expert and get back to you.

Email

If you have submitted a question above, leave your email so we can get back to you.

Submit